# NAROPIN
> **NDA020533** · New Drug Application · Sponsor: FRESENIUS KABI USA · Approved 1996-09-24
## Drug
- **FDA Application Number:** NDA020533
- **Application type:** New Drug Application
- **Brand name:** NAROPIN
- **Generic name:** ROPIVACAINE HYDROCHLORIDE
- **Active ingredients:** ROPIVACAINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 1996-09-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020533)
---
*MORVS · CC0 1.0*